Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.64 |
| ▸ | ADRB1 | P08588 | 6/20 | 0.62 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.60 |
| ▸ | HTR6 | P50406 | 3/20 | 0.56 |
| ▸ | HTR7 | P34969 | 3/20 | 0.56 |
| ▸ | HTR3E | A5X5Y0 | 3/20 | 0.56 |
| ▸ | HTR3B | O95264 | 3/20 | 0.56 |
| ▸ | HTR3A | P46098 | 3/20 | 0.56 |
| ▸ | HTR3D | Q70Z44 | 3/20 | 0.56 |
| ▸ | HTR3C | Q8WXA8 | 3/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.56 |
| ▸ | HTR1A | P08908 | 2/20 | 0.56 |
| ▸ | HTR2A | P28223 | 2/20 | 0.56 |
| ▸ | HTR5A | P47898 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | NCF1 | P14598 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | HTR1D | P28221 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4684126 | 0.98 | KEAP1 (0.62) | KEAP1ADRB1ADRA2CHTR6HTR7 | |
| SCHEMBL3546559 | 0.93 | KEAP1 (0.67) | KEAP1ADRB1ADRA2CHTR6HTR7 | |
| SCHEMBL27597451 | 0.88 | KEAP1 (0.55) | KEAP1ADRB1ADRA2CHTR6HTR7 | |
| Hydrochloric Acid SCHEMBL11019496 | 0.86 | KEAP1 (0.53) | KEAP1ADRB1ADRA2CHTR6HTR7 | |
| SCHEMBL16892744 | 0.85 | HTR7 (0.65) | ADRB1HTR6HTR7HTR3EHTR3B | |
| SCHEMBL23152040 | 0.84 | ADRA2C (0.79) | KEAP1ADRB1ADRA2CMEN1USP2 | |
| SCHEMBL15834279 | 0.84 | ADRB1 (0.75) | ADRB1HTR6HTR7HTR3EHTR3B | |
| SCHEMBL11775877 | 0.84 | ADRA2C (0.79) | KEAP1ADRB1ADRA2CMEN1USP2 | |
| Tert-Butyl Formate SCHEMBL27790951 | 0.82 | ADRB1 (0.47) | KEAP1ADRB1ADRA2CHTR6HTR7 | |
| SCHEMBL3033168 | 0.81 | ADRB1 (0.50) | ADRB1HTR6HTR7HTR3EHTR3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011344-A | Photo-thermal stable PTAA copolymer and preparation method thereof | 链行走新材料科技(广州)有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-10907085-B2 | Swellable glass particles for reducing fluid flow in subterranean formations | HALLIBURTON ENERGY SERVICES, INC. (US) | 2021-02-02 | — | — | US | claimed |
| EP-2391692-B1 | METHODS FOR SERVICING WELL BORES WITH HARDENABLE RESIN COMPOSITIONS | HALLIBURTON ENERGY SERVICES INC (US) | 2018-05-16 | — | — | EP | claimed |
| US-20160194544-A1 | EPOXY RESIN FORMULATIONS CONTAINING AN IMPACT MODIFIER FOR USE IN SUBTERRANEAN WELLS | HALLIBURTON ENERGY SERVICES, INC. | 2016-07-07 | — | — | US | claimed |
| US-9353107-B2 | 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors | AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) | 2016-05-31 | — | — | US | claimed |
| WO-2016024990-A1 | NAPTHOL-BASED EPOXY RESIN ADDITIVES FOR USE IN WELL CEMENTING | HALLIBURTON ENERGY SERVICES, INC. (US) | 2016-02-18 | — | — | WO | claimed |
| US-20160046853-A1 | Napthol-Based Epoxy Resin Additives For Use In Well Cementing | HALLIBURTON ENERGY SERVICES, INC. (US) | 2016-02-18 | — | — | US | claimed |
| US-20150336949-A1 | 3-(Pyrazolyl)-1H-Pyrrolo[2,3-b]Pyridine Derivatives as Kinase Inhibitors | Um Pharmauji Sdn. Bhd. (MY) | 2015-11-26 | — | — | US | claimed |
| WO-2015034473-A1 | EPOXY RESIN FORMULATIONS CONTAINING AN IMPACT MODIFIER FOR USE IN SUBTERRANEAN WELLS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-03-12 | — | — | WO | claimed |
| US-20130109782-A1 | COMPOSITIONS AND METHODS FOR IMPROVING THE TOUGHNESS OF SET CEMENTS | SCHLUMBERGER TECHNOLOGY CORPORATION | 2013-05-02 | — | — | US | claimed |
| US-20130105162-A1 | COMPOSITIONS AND METHODS FOR IMPROVING THE TOUGHNESS OF SET CEMENTS | SCHLUMBERGER TECHNOLOGY CORPORATION | 2013-05-02 | — | — | US | claimed |
| WO-2010086592-A1 | METHODS FOR SERVICING WELL BORES WITH HARDENABLE RESIN COMPOSITIONS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2010-08-05 | — | — | WO | claimed |
| US-20100186956-A1 | Methods for Servicing Well Bores with Hardenable Resin Compositions | HALLIBURTON ENERGY SERVICES, INC. | 2010-07-29 | — | — | US | claimed |
| US-7762329-B1 | Methods for servicing well bores with hardenable resin compositions | HALLIBURTON ENERGY SERVICES, INC. (US) | 2010-07-27 | — | — | US | claimed |
| CN-122011344-A | Photo-thermal stable PTAA copolymer and preparation method thereof | 链行走新材料科技(广州)有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-3623398-B1 | RESIN COMPOSITION COMPRISING A MODIFIED BLOCK COPOLYMER AND METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER | ASAHI CHEMICAL IND (JP) | 2024-08-28 | — | — | EP | disclosed |
| CN-115353509-B | Nitrogen-containing heteroaromatic derivative regulator, preparation method and application thereof | 江苏豪森药业集团有限公司 | 2024-04-12 | — | — | CN | disclosed |
| EP-0321131-A2 | Triazole antifungal agents | Pfizer Limited (GB) | 1989-06-21 | — | — | EP | disclosed |
| US-4668681-A | ANTIALLERGENS, ANAPHYLAXIS, MOTION SICKNESS | SOCIETE CORTIAL, S.A. (FR) | 1987-05-26 | — | — | US | disclosed |
| US-4590193-A | 3-(2-(4-phenylpiperazinylethyl)anilino)-isobenzofuranones, their method of preparation and their use as antihypertensive and antiallergic drugs | SOCIETE CORTIAL, S.A. (FR) | 1986-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150336949-A1 | 3-(Pyrazolyl)-1H-Pyrrolo[2,3-b]Pyridine Derivatives as Kinase Inhibitors | MAP3K3, MAP3K1, MAP3K6 | KEAP1 1033/4885ADRB1 1235/4885ADRA2C 1550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.